Assay and Drug Development Technologies

Papers
(The H4-Index of Assay and Drug Development Technologies is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
On the Recent Changes to Animal Protection Measures in United States Food and Drug Administration Policy37
Call for Special Issue Papers: New Modalities in Chemical Probes and Pharmacological Tools in Drug Discovery18
Call for Special Issue Papers: Chemical Probes and Pharmacological Tools for Imaging Applications18
A Perspective on Various Facets of Nanoemulsions and its Commercial Utilities18
Identification of Potential Molecular Targets of Doxorubicin for Application in Skin Cancer: A Network Pharmacology and Molecular Docking Perspective13
Beyond the Maze: Recent Advancements in Molecular and Cellular Tethered Drug Delivery Systems13
α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line13
Novel Therapeutics Involving Antibiotic Polymer Conjugates for Treating Various Ailments: A Review13
Acknowledgment of Reviewers 202112
Call for Special Issue Papers: Chemical Probes and Pharmacological Tools for Kinase Signaling12
Mini Review on the Lyophilization: A Basic Requirement for Formulation Development and Stability Modifier12
Silibinin-Loaded Nanostructured Lipid Carriers for Growth Inhibition of Cisplatin-Resistant Ovarian Cancer Cells11
0.047470092773438